In today’s briefing, we explore generative AI developments across various sectors. From Adobe Acrobat’s latest generative AI feature for interactive document management to Bioptimus’s seed funding to train an LLM only on biology. Discover how Scale AI is guiding the Pentagon in AI evaluations, the impact of quantum-enhanced AI on cancer drug discovery, and the growing importance of GPTs in professional settings.
Timestamps:
0:00:26 Adobe Acrobat Integrates Generative AI for Document Interaction
0:04:19 Bioptimus Raises $35M for AI in Biology
0:07:57 Scale AI Partners with Pentagon for AI Testing
0:12:41 Quantum-Enhanced AI in Cancer Drug Discovery
0:19:00 Exploring 20 Workplace GPTs with Lenny Richesky
Key Highlights:
– Adobe Acrobat enables users to interact with documents, making navigation and information retrieval more intuitive.
– Bioptimus embarks on a mission to revolutionize the biological sciences with a substantial seed funding round, emphasizing the potential of AI in foundational biology models.
– Scale AI sets a new standard for AI evaluation in defense, reflecting on the Pentagon’s strategic move towards ethical and efficient AI deployment.
– Quantum Computing merges with generative AI to fast-track cancer drug development, showcasing a significant leap in healthcare innovation.
– GPTs at Work: Insights from Lenny Rachitsky’s newsletter highlight the versatility of GPTs in enhancing productivity and creativity in professional environments.
Join us every weekday at 7:30 AM ET on LinkedIn or YouTube for comprehensive discussions on AI. Engage with our community live and share your perspectives:
https://www.linkedin.com/company/gai-insights/
Our analysts: Paul Baier, John Sviokla, Tim Andrews, David De Lallo, Tania DiCostanzo, Amanda Fetch, Luda Kopeikina, and Adam Rappaport.
Add comment